CRL vs SLVM · rev $2.00B vs P/E 15, rev $1.56B
Charles River Laboratories (CRL) versus Sylvamo Corp (SLVM) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Sylvamo Corp (SLVM) is a paper & paper products company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported SLVM revenue for 2026-06-30 was $1.56B. Net income was -$14.0M. SLVM currently screens at market cap $1.54B and trailing P/E 15.4.
CRL currently screens at market cap $7.78B. SLVM currently screens at market cap $1.54B and trailing P/E 15.4.
Not investment advice. Open the CRL and SLVM stock pages for the full models.
Not investment advice.